Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Areata”

656 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 656 results

Not applicableStudy completedNCT01016964
What this trial is testing

Treatment of Androgenetic Alopecia in Females, 12 Beam

Who this might be right for
Androgenetic AlopeciaHair LossFemale Pattern Baldness
Lexington International, LLC 63
Testing effectiveness (Phase 2)Looking for participantsNCT05398809
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Who this might be right for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)Alopecia Areata
National Institute of Allergy and Infectious Diseases (NIAID) 70
Large-scale testing (Phase 3)Study completedNCT03732807
What this trial is testing

PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 718
Testing effectiveness (Phase 2)Ended earlyNCT05556265
What this trial is testing

Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Who this might be right for
Alopecia Areata
Bristol-Myers Squibb 94
Testing effectiveness (Phase 2)Study completedNCT06393452
What this trial is testing

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Who this might be right for
Androgenetic Alopecia
Pelage Pharmaceuticals, Inc. 78
Not applicableLooking for participantsNCT04764331
What this trial is testing

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Who this might be right for
Central Centrifugal Cicatricial Alopecia
Wake Forest University Health Sciences 5
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Testing effectiveness (Phase 2)Study completedNCT03467412
What this trial is testing

To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

Who this might be right for
Androgenic Alopecia
Follicum AB 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018428
What this trial is testing

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Who this might be right for
Alopecia Areata
Q32 Bio Inc. 75
Not applicableWithdrawnNCT03335228
What this trial is testing

Platelet Rich Plasma for Frontal Fibrosing Alopecia

Who this might be right for
Frontal Fibrosing Alopecia
University of Minnesota
Not applicableLooking for participantsNCT07502976
What this trial is testing

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Who this might be right for
Androgenic Alopecia
Kasr El Aini Hospital 60
Not applicableStudy completedNCT02494297
What this trial is testing

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

Who this might be right for
HirsutismAndrogenetic AlopeciaSevere Anemia+2 more
Center for Epidemiology and Health Research, Germany 1,597
Post-approval studies (Phase 4)UnknownNCT03388840
What this trial is testing

Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction

Who this might be right for
Androgenetic Alopecia
Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT02974868
What this trial is testing

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 142
Not applicableWithdrawnNCT02486848
What this trial is testing

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Who this might be right for
Female Pattern Hair LossAndrogenetic Alopecia
Maja Kovacevic, MD
Not applicableUnknownNCT03289364
What this trial is testing

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

Who this might be right for
Breast Cancer
Providence Health & Services 9
Early research (Phase 1)Study completedNCT01189279
What this trial is testing

Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

Who this might be right for
AlopeciaAlopecia, AndrogeneticBaldness
Allergan 42
Post-approval studies (Phase 4)Study completedNCT01167946
What this trial is testing

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Who this might be right for
Alopecia TotalisAlopecia UniversalisOphiasic Alopecia
King Saud University 42
Not applicableUnknownNCT02316418
What this trial is testing

Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)

Who this might be right for
Female Pattern BaldnessAlopecia, Androgenetic
Hairstetics 10
Post-approval studies (Phase 4)Study completedNCT04090801
What this trial is testing

Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss

Who this might be right for
Female Pattern Hair Loss
Sohag University 60
Load More Results